Dyadic International Receives Nasdaq Notice Over Low Share Price, MVLS

What Happened
Dyadic International, Inc. (DYAI) announced in an 8-K that on September 25, 2026 it received two deficiency notices from Nasdaq Listing Qualifications: one for failing to maintain the minimum $1 per-share bid price under Nasdaq Listing Rule 5550(a)(2), and a separate notice for failing to maintain the minimum Market Value of Listed Securities (MVLS) of $35 million under Rule 5550(b)(2). The notices have no immediate delisting effect but start a 180-calendar-day compliance period that runs through March 24, 2027. To regain compliance the company must have its bid price at $1.00 or more and/or its MVLS at $35 million or more for at least 10 consecutive business days before that date (subject to Nasdaq discretion to extend).

Key Details

• Date of notices: September 25, 2026.
• Minimum bid price requirement: $1.00 per share (Rule 5550(a)(2)).
• Minimum MVLS requirement: $35 million (Rule 5550(b)(2)).
• Compliance deadline: March 24, 2027 (180 days); may be eligible for an additional 180-day cure period if other listing standards are met on the Compliance Date and the company files intent to cure (e.g., via reverse stock split).
• Company options: monitor stock, evaluate actions (including reverse split), and may appeal any delisting determination to a Nasdaq hearings panel.

Why It Matters
A failure to regain compliance could lead to Nasdaq delisting, which can reduce liquidity, limit investor access to the stock, and negatively affect share price and valuation. Dyadic says it will monitor its bid price and MVLS and consider options to cure the deficiencies; however, delisting appeals are not guaranteed to succeed. Retail investors should note the compliance timeline, the technical fixes the company may pursue (such as a reverse stock split), and the broader risks disclosed in Dyadic’s SEC filings.